Melanoma Diagnosis, Outcomes and Survival

5 (1 vote)

Recorded On: 10/26/2023

Only available as part of a package

This presentation will provide an overview of melanoma across the cancer continuum, from early diagnosis through therapeutic options for metastatic melanoma. It will cover emerging concepts in metastatic melanoma care, including neoadjuvant therapy for patients with locally advanced disease and the gut microbiome and immunotherapy response.

At the end of this session, participants will be able to:

List evidence-based approaches to early melanoma detection.
Understand the changing landscape of metastatic melanoma therapeutics and outcomes.
Appreciate the benefits to neoadjuvant therapy for regionally advanced melanoma.
Understand the role of the gut microbiome and response to immune checkpoint blockade therapy.

Orit Markowitz, MD

Dr. Orit Markowitz is a leading dermatologist, skin cancer specialist, and CEO and Founder of Markowitz Medical. She has been called a dermatologic pioneer for her groundbreaking work developing minimally-invasive diagnostic and treatment protocols for skin cancer. Her motto: Cutting Edge Without the Cutting™

Over the past decade, Dr. Markowitz has served as Director of Pigmented Lesions and Skin Cancer at both Mount Sinai Department of Dermatology and Brooklyn Veterans Hospital of Downstate University Medical Center, as well as Associate Professor of Dermatology at Mount Sinai and SUNY Downstate University Medical Center.

Dr. Markowitz is considered a leading educator in noninvasive skin cancer therapies. She has directed imaging courses for the American Academy of Dermatology (AAD), she trains all residents in the greater New York area on dermoscopy, and she wrote A Practical Guide to Dermoscopy, the leading handbook on the topic. Dr. Markowitz has also lectured at numerous AAD conferences, is President of the International Optical Coherence Tomography Society, Chair of the AAD’s Quality Assurance and Education Committee Cutaneous Imaging Group, and she was the chair of the Second World Congress of Confocal Microscopy Conference.

Considered one of the world’s leading researchers in nonsurgical skin cancer treatment, Dr. Markowitz opened Markowitz Medical, in part, to act as her primary research lab. Dr. Markowitz has acted as principal investigator in multiple U.S. clinical trials studying the use of noninvasive imaging in skin cancer, precancer, psoriasis and eczema, and her most recent funded imaging research includes early diagnosis and optimal management of skin cancer and prognostic indicators of medications on disease, such as field cancerization, psoriasis, atopic dermatitis, nail fungus and allergy patch testing. Dr. Markowitz was the recipient of 2018 Melanoma Research Humanitarian Award for her groundbreaking work in early melanoma diagnosis and significant contributions to the treatment and care of melanoma patients.